Sign In
Buy EBS
$7.93
-0.280 (-3.41%)
At Close: Jun 03, 2026
New York, New York--(Newsfile Corp. - June 3, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Eme
RADNOR, Pa., June 2, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds Emergent BioSolutions Inc. (NYSE: EBS) ("Emergent") investors that the firm has filed a securities
New York, New York--(Newsfile Corp. - June 2, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Eme
New York, New York--(Newsfile Corp. - June 1, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Emergent Biosolutions Inc..Sha
EBS LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Emergent Biosolutions Inc.
03:30pm, Tuesday, 01'st Jun 2021
New York, New York--(Newsfile Corp. - June 1, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Emergent Biosolut
New York, New York--(Newsfile Corp. - June 1, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Emergent Biosolutions Inc. (NYSE: EBS) alle
New York, New York--(Newsfile Corp. - June 1, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Eme
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Emergent BioSolutions Inc. - EBS
05:15am, Tuesday, 01'st Jun 2021
NEW YORK, June 1, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Emergent BioSolutions Inc. ("Emergent" or the "Company") (NYSE: EBS). Such investors are advi
Radnor, Pennsylvania--(Newsfile Corp. - May 31, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP announces that Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action a
New York, New York--(Newsfile Corp. - May 30, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Eme
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Emergent BioSolutions Inc. - EBS
11:19pm, Saturday, 29'th May 2021
New York, New York--(Newsfile Corp. - May 29, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Emergent BioSolutions Inc. ("Emergent" or the "Company") (NYSE: EBS). Such investo
New York, New York--(Newsfile Corp. - May 29, 2021) - WHY:. Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between Ap
Kessler Topaz Meltzer & Check, LLP: Reminds Investors of Securities Fraud Class Action Filed Against Emergent BioSolutions Inc.
04:24pm, Friday, 28'th May 2021
RADNOR, Pa., May 28, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action against Emerg
Emergent BioSolutions Poised To Receive FDA Nod to Restart J&J COVID-19 Shot Production at Baltimore Plant After Mishap: WSJ
11:37am, Friday, 28'th May 2021
The FDA and Johnson & Johnson (NYSE: JNJ) are expected to announce that contamination problems at Emergent BioSolutions Inc's (NYSE: EBS) Baltimore Bayview plant have been resolved, and production
New Orleans, Louisiana--(Newsfile Corp. - May 28, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have un
